[123I]MNI-420

MNI-420 · Institute for Neurodegenerative Disorders

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [123I]MNI-420, covering 2017-01-06 to 2017-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects. [Phase 1]

See pricing